Expert Review of Pharmacoeconomics & Outcomes Research (ISSN 1473-7167) provides expert reviews on cost-benefit and pharmacoeconomic issues relating to the clinical use of drugs and therapeutic approaches. Coverage includes pharmacoeconomics and quality-of-life research, therapeutic outcomes, evidence-based medicine and cost-benefit research. All articles are subject to rigorous peer-review. 
  
The journal adopts the unique Expert Review article format, offering a complete overview of current thinking in a key technology area, research or clinical practice, augmented by the following sections: 
  
Expert Opinion – a personal view of the data presented in the article, a discussion on the developments that are likely to be important in the future, and the avenues of research likely to become exciting as further studies yield more detailed results 
Article Highlights – an executive summary of the author’s most critical points 
   
All reviews are subject to peer review, with a minimum of three independent evaluations. 

Senior Editor
Annemans L, University of Ghent, Belgium   
  
Associate Editors 
Cleeland C, MD Anderson Cancer Center, TX, USA 
Flechtner H-H, University of Magdeburg, Germany 
Gotay C, University of British Columbia, Canada 
Taphoorn MJB, Medical Centre Haaglanden, The Netherlands
Editorial Board
Aaronson NK, The Netherlands Cancer Institute, The Netherlands 
Ashcroft DM, University of Manchester, UK 
Awad AG, Humber River Regional Hospital, Toronto, Canada 
Badia X, IMS Health, Spain 
Bottomley A, EORTC, Belgium  
Bridges J, Ohio State University College of Medicine, Columbus, OH 
Brixner D, University of Utah, UT, USA 
Cella D, Northwesern University, IL, USA 
Chow E, Sunnybrook Regional Cancer Center, CA, USA 
Coens C, EORTC, Belgium 
Darba J, University of Barcelona, Spain 
DeKoven MP, IMS Health, Inc., VA, USA 
Fatoye F, Manchester Metropolitan University, Manchester, UK 
Ferreira PL, Universidade Coimbra, Portugal 
Gans-Combe C, Reihoo, France 
Garattini L, CESAV - Mario Negri Institute, Italy 
Garg V, Abbvie, IL, USA 
Greimel E, University of Graz, Austria 
Hartzema AG, University of Florida, FL, USA 
Hiligsmann M, Maastricht University, The Netherlands 
Ikegami N, Keio University, Japan 
Jakovljevic M, University of Kragujevac, Serbia 
Khan ZM, Celgene Corporation, NJ, USA 
King M, University of Sydney, Australia 
Krabbe PFM, University Medical Center Groningen, The Netherlands 
LeGrand C, Univ. Catholique de Louvain, Belgium 
Mendoza RL, Wilmington University, DE, USA 
Minshall ME, Strategic Consulting & Outcomes Research, IN, USA 
Motheral B, Artemetrx LLC., TN, USA 
Neumann PJ, Tufts University School of Medicine, MA, USA 
Pavlovic-Ganascia M, AFSSAPS, France 
Postma M, Groningen University, The Netherlands 
Raisch DW, University of New Mexico, NM, USA 
Ramjiawan B, St Boniface General Hospital Research Centre, Canada 
Ramsey S, Fred Hutchinson Cancer Research Center, WA, USA 
Rubenstein LZ, University of Oklahoma College of Medicine, USA 
Sankaranarayanan J, University of Connecticut, USA 
Sculpher M, University of York, UK 
Sendi P, University of Basel, Switzerland 
Shaya FT, University of Maryland, MD, USA 
Simoens S, Katholieke Universiteit Leuven, Belgium 
Sloan J, Mayo Clinic/Medical School, MN, USA 
Summers KH, Astellas Pharma, IL, USA 
Wilson L, University of California San Francisco, CA, USA 
Younis MZ, Jackson State University, FL, USA 
Yfantopoulos J, University of Athens, Greece